Shockwave Medical Reports First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff pulls Wall Street to two-week lows as oil and yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Tech selloff pulls Wall Street to two-week lows as oil and yields climb
- Trump threatens to bomb Oman over Iran stance
Shockwave Medical (SWAV) Tops Q1 EPS by 23c; Guides Higher
May 9, 2022 4:12 PM EDTShockwave Medical (NASDAQ: SWAV) reported Q1 EPS of $0.41, $0.23 better than the analyst estimate of $0.18. Revenue for the quarter came in at $93.6 million versus the consensus estimate of $86.41 million.
GUIDANCE:
Shockwave Medical sees Q2 2022 revenue of $435-455 million, versus the consensus of... More
